User:Mr. Ibrahem/Carfilzomib

Carfilzomib, sold under the brand name Kyprolis, is a medication used to treat multiple myeloma (MM). It is used in those who have not improved with other treatment. It is given by injection into a vein.

Common side effects include low red blood cells, tiredness, nausea, diarrhea, low platelets, fever, shortness of breath, cough, and low white blood cells. Other side effects may include heart problems, liver problems, lung problems, kidney problems, bleeding, infection, and high blood pressure. Use in pregnancy may harm the baby. It is a proteasome inhibitor.

Carfilzomib was approved for medical use in the United States in 2012 and Europe in 2015. In the United Kingdom it costs the NHS about £1,050 for 60 mg as of 2021. In the United States this amount costs about 2,700 USD.